종목/IVF
I
인보 퍼틸러티
IVFNasdaqCM· HealthcareINVO Fertility, Inc.
$1.48
종가· 6. 15.
$3M
시가총액
$1.48
6. 15. 종가
시가총액
$3M
MISS6월 22일 (월)장전실제값2026 Q1 실적 발표 결과
EPS 실제
$-3.38
예상 $-1.26
Surprise
−167.7%
매출
$2M
예상 $2M
발표 직후 반응
−7.3%
5일 +63.3%
최근 2분기:
·이번 분기는 Miss, 2연속 Miss 행진
동종업계 비교
Healthcare · 시총 상위기업 정보
섹터Healthcare
산업Medical Devices
대표이사—
상장일11월 11일 (화)
발행주식수1.8M주
직원수40명
회사 소개 보기
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.
분기 실적 히스토리
최근 2분기| 발표일 | 분기 | EPS 예상 | EPS 실제 | Surprise | 매출 실제 | 발표 직후 반응 |
|---|---|---|---|---|---|---|
| 6월 22일 (월) | 2026 Q1 | $-1.26 | $-3.38 | −167.7% | $2M | ▼ −7.3% |
| 6월 2일 (화) | 2025 Q4 | $-2.78 | $-196.81 | −6985.9% | $2M |